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We investigated the impact of curcumin on neutrophils. Chemotactic activity via human recombinant IL-8 (hrIL-8) was signiﬁ-
cantly inhibited by curcumin. Curcumin reduced calcium ion ﬂow induced by internalization of the IL-8 receptor. We analyzed
ﬂow cytometry to evaluate the status of the IL-8 receptor after curcumin treatment. The change in the distribution of receptors
intracellularly and on the cell surface suggested that curcumin may aﬀect the receptor traﬃcking pathway intracellulary. Rab11 is
a low molecular weight G protein associated with the CXCR recycling pathway. Following curcumin treatment, immunoprecipi-
tation studies showed that the IL-8 receptor was associated with larger amounts of active Rab11 than that in control cells. These
data suggest that curcumin induces the stacking of the Rab11 vesicle complex with CXCR1 and CXCR2 in the endocytic pathway.
The mechanism for antiinﬂammatory response by curcumin may involve unique regulation of the Rab11 traﬃcking molecule in
recycling of IL-8 receptors.
Copyright © 2007 Masafumi Takahashi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Curcumin(17-bis(4-hydroxy-3-methoxyphenyl)-1,6-hepta-
diene-3,5-dione) extracted from Curcuma longa L. is gener-
ally used as a spice and as a coloring agent in food [1, 2].
Curcumin is also used in traditional medicine to treat the in-
ﬂammatory diseases [3].
Curcumin has anti-inﬂammatory and antioxidant eﬀects
and downregulates chemokine expression in inﬂammatory
cells [1, 4, 5]. Curcumin aﬀects kinase reactions, such as
those of MAP kinase, and PKC, c-Jun/AP-1 [6, 7]. Further-
more,severalresearchers,includingourgroup,havereported
that curcumin blocks NF-kB activity during transcription
[8, 9]. The molecular mechanism of NF-kB inhibition in-
volves the blocking of IkB phosphorylation in a human non-
transforming epithelial cell line [9, 10]. Although the in-
hibitory eﬀect of curcumin on inﬂammatory responses is
wellknown[11,12],thecontributionofcurcumintothesig-
nal transduction pathway in the proinﬂammatory cytokine
response remains unclear.
IL-8 belongs to the CXC chemokine subgroup. It is
a chemotactic cytokine that activates and elicits the mi-
gration of leukocyte [13]. IL-8 aﬀects the functions of
human neutrophils, including enhanced chemotaxis, en-
zyme release, and expression of surface adhesion molecules.
IL-8 stimulates neutrophils via speciﬁc chemokine re-
ceptors, namely, the IL-8 receptors. These receptors are
seven-transmembrane guanine nucleotide-binding protein-
coupled receptors (GPCRs). IL-8 receptors are membrane-
bound proteins expressed in large amount in primary cul-
tured neutrophils. Humans have two high-aﬃnity recep-
tors for IL-8, namely, CXCR1 and CXCR2. The sequences
of these receptors show 77% homology [13, 14]. Receptor-
mediated signal transduction is initiated by coupling with
heterotrimeric G proteins, and this results in an increase in
the cytosolic free Ca2+ concentration due to activation by
IL-8 [14, 15]. CXCR1 has limited activators, such as IL-8;
however, CXCR2 has numerous activator cytokines, that is,
CXC chemokines such as NAP-2 and GROα [16, 17]. Re-
cent evidence has suggested that IL-8 receptors internalize2 Mediators of Inﬂammation
via clathrin-coated vesicle upon agonist binding [18, 19]. Af-
ter the release of the agonist, the IL-8 receptors are trans-
ported from the cytoplasm to the nucleus; some of the re-
ceptors are transported back to the cell surface via the re-
cycling endosomes. This phenomenon is termed as “recy-
cling.” CXCR1 is recycled to the cell surface more rapidly
than CXCR2 [17, 19–22]. It was reported that CXCR1 is the
dominant mediator of the neutrophil chemotactic response
to IL-8 [23]. Thus, CXCR1 is involved in the crucial process
of neutrophil-induced inﬂammation.
We previously reported that IL-8 and its receptors were
constitutively produced by pancreatic cancer cells. In addi-
tion, the autocrine growth eﬀect of IL-8 is blocked by cur-
cumin [8]. In this process, curcumin contributes not only to
theinhibitionofIL-8productionbutalsototheinhibitionof
signal transduction via IL-8 receptors. These data suggested
that curcumin is a potent agent that blocks the IL-8 receptor-
mediated neutrophil responses.
In this study, we investigated the eﬀect of curcumin on
neutrophil chemotaxis mediated by IL-8 and determined
whether curcumin treatment inhibits signal transduction
from the IL-8 receptor in human primary neutrophils. We
designed the study in order to test the hypothesis that cur-
cumin treatment has an eﬀect on the endosomal traﬃcking
pathway of IL-8 receptors.
Therefore, the endosomal vesicles that participate in the
traﬃcking of IL-8 receptors may play an important role in
the curcumin-mediated regulation. The Rab proteins Ras-
related small guanosine-5 -triphosphatases (GTPases) might
be essential since they are involved in the mechanisms of
traﬃcking intracellular vesicles to the target organs [24–26].
More than 60 types of Rab proteins were found, and they
play a role in regulating some of the steps involved in the in-
tracellular traﬃcking of target molecules [25]. Considerable
evidence showed that CXCR2 and Rab11 coexist in the re-
cycling step of CXCR2-transfected cells [27, 28]. These data
suggested that Rab11 might be a key mediator in the distri-
bution and traﬃcking pathway of IL-8 receptors upon cur-
cumin treatment.
In this study, our data showed that curcumin treatment
regulated the recycling of IL-8 receptors and the amount of
cell surface IL-8 receptors. This change may be closely asso-
ciated with the anti-inﬂammatory response caused by the in-
terference of the chemotactic activity of IL-8.
2. MATERIALS AND METHODS
2.1. Reagents
Curcumin was purchased from Sigma (St. Louis, Mo, USA).
Polymorphprep was obtained from Axis-Shield (Oslo, Nor-
way). IntraPrep permeabilization reagent was obtained from
Immunotech (Marseille, France), rIL-8 from R&D Systems
Inc. (minneapolis, Minn, USA), Diﬀ-Quick from Midori Juji
(Osaka, Japan), Fura Red-AM from Molecular Probes (Eu-
gene, Ore, USA). Anti-CXCR1 mouse monoclonal IgG1 was
purchased from Santa Cruz Biotechnologies (Santa Cruz,
Calif, USA). Anti-CXCR2 mouse monoclonal IgG1,m o u s e
IgG1,allophycocyanin(APC)-conjugatedratantimouseIgG1
monoclonal antibody, and puriﬁed mouse IgG1 monoclonal
IgG standard were purchased from BD Pharmingen (San
Diego, Calif, USA). Human IgG was purchased from Sigma.
Cycloheximide was purchased from Wako Pure Chemical In-
dustries Ltd. (Osaka, Japan).
2.2. Neutrophilisolation
Neutrophils were isolated from the peripheral venous blood
of healthy human volunteers. Heparinized whole blood was
layered onto Polymorphoprep (Axis-Shield PoC AS) and
centrifuged at 500xg for 35 minutes. The supernatant and
the peripheral blood mononuclear cell (PBMC) layers were
discarded. The polymorphonuclear neutrophil (PMN) layer
was removed, and hyposmotic hemolysis was performed for
the remaining erythrocytes. Since NH4Cl, a lysosomotrophic
agent,mayinhibitreceptortraﬃckinginhumanneutrophils,
the neutrophils used in these experiments were prepared
without NH4Cl. The PMNs were resuspended in RPMI 1640
medium containing 10% fetal calf serum (FCS). The pu-
rity of the neutrophil preparations was routinely found to be
greaterthan95%withviabilitygreaterthan98%,asobserved
by trypan blue exclusion test.
2.3. Curcumintreatment
Curcumin was dissolved in dimethyl sulfoxide (DMSO) on
the day of use, and was added to the cells at a ﬁnal concen-
tration of 0.5–100μM. The DMSO concentration was always
less than 0.1% (vol/vol).
2.4. Trypanbluestaining
Trypanbluesolution(0.4%)wasaddedtothecellsuspension
(ﬁnal concentration, 0.2%). After treatment with curcumin
(10–100μM) for 2 hours, the number of positive cells was
counted in triplicate.
2.5. Neutrophilchemotaxsisassay
Chemotaxis was assessed by a modiﬁcation of a previously
described method; 24-well microchemotaxis chambers (Bec-
ton Dickinson, Cowley, UK) were used, and these were cov-
ered with polyethylene terephthalate membranes with pore
size of 3μm[ 29, 30]. The lower wells were ﬁlled with 700μL
of medium with various concentrations of recombinant hu-
m a nI L - 8( h r I L - 8 )( 1 0∼ 10000ng/mL) or medium with-
out hrIL-8. Subsequently, 700μL of a suspension contain-
ing 1 × 106 PMNs was added to each well of the upper
chamber. After incubation under conditions of 90% humid-
ity and 5% CO2 for 1 hour at 37◦C, the cells that passed
through the ﬁlter to the lower wells were stained with Diﬀ-
Quick and counted in 5 high-power ﬁelds (hpf, 40 × 10) us-
ing a calibrated grating. Neutrophil chemotactic activity was
determined in triplicates and expressed as the average num-
ber of migrating neutrophils/5 hpf.
Next, to determine the eﬀe c to fc u r c u m i no nn e u t r o p h i l
chemotaxis, the neutrophils were preincubated with various
concentrations of curcumin (10 ∼ 100μM) at 37◦Cf o r2Masafumi Takahashi et al. 3
hours.Thepreincubatedneutrophilswereaddedtoeachwell
of the upper chamber and incubated for 1 hour, as described
above. The cells that passed through the ﬁlter to the lower
wells were stained and counted. The data obtained was ex-
pressed as described above.
2.6. Measurementofcytosoliccalcium
The obtained neutrophils were colored yellow by curcumin
thathasabimodalpeakofabsorptionat210nmand425nm.
The color causes ﬂuorescence noise when using optical in-
struments. To avoid interference due to the ﬂuorescence
noise, we used Fura Red because it shows decreased red ﬂu-
orescence that is not interfered by curcumin. Neutrophils
(1 × 107 cells/mL) were loaded with 13μM Fura Red-AM in
HEPES-buﬀered saline (135mM NaCl, 4.6mM KCl, 1.2mM
MgCl2,1 1 m MH E P E S ,1 1 m Mg l u c o s e ,1 . 5 m MC a C l 2,a t
pH 7.4) for 90 minutes at 37◦Ci naC O 2 incubator. The
loaded neutrophils were then analyzed using a FACS calibur
system (Beckton Dickinson, USA) for analyzing red ﬂuores-
cence (640nm) following excitation at 488nm using an ar-
gon laser. The mean channel of ﬂuorescence was detected by
CellQuest software (Beckton Dickinson) [31, 32]. The mea-
surements of the mean channel of ﬂuorescence can be used
for statistical comparison of the cells before and after hrIL-
8 treatment. The data obtained showed diﬀerences between
the mean channel value before and after IL-8 stimulation.
2.7. AnalysisofCXCRinternalization
Internalization analysis was performed as previously de-
scribed [8, 15]. In brief, neutrophils were preincubated with
RPMI 1640 medium containing 10% FCS supplemented
with 50μM curcumin or without curcumin at 37◦Cf o r2
hours. The cells were washed twice in PBS and once in
bovineserumalbuminmedium(BSAmedium =RPMI1640
medium containing 1% bovine serum albumin and 25mM
HEPES).Aliquotsof5×106 cellswerethenremovedandsup-
plemented with 50ng/mL hrIL-8 diluted in BSA medium,
while no hrIL-8 was added to the control tubes. The cells
were incubated at 37◦C for 2 hours and then incubated for
an additional 10 minutes on ice. The cells were washed us-
ing the cell sorter buﬀer (CSB: PBS containing 1% FCS,
0.02% NaN3, and 25mM HEPES) and incubated at 4◦Cf o r
15 minutes with human IgG to block the Fc receptors. They
were washed twice with CSB and incubated with either mon-
oclonal mouse anti-CXCR1 or anti-CXCR2 antibody and
mouse-IgG1a as the control. Following the 15-minute in-
cubation, the cells were washed twice in CSB, and APC-
conjugated rat antimouse IgG antibody was added and incu-
bated at 4◦C for 15 minutes. Since APC emission is collected
in a detector for ﬂuorescence wavelengths between 640nm
and 680nm, in these experiments, interference by curcumin
ﬂuorescence should be avoided.
Thecellswere then washedoncein CSB and resuspended
in PBS containing 0.02% NaN3. Flow cytometry was per-
formed using the FACS calibur system. It was used to analyze
10000 live cell events.
2.8. Stainingofbothcellsurfaceand
intracytoplasmicCXCR
The neutrophils were permeabilized using the IntraPrep per-
meabilization reagent, including reagents 1 and 2, accord-
ing to the manufacturer’s instructions [33]. In brief, to stain
CXCR present on the surface of the cell membrane, the neu-
trophils were incubated with a primary antibody at 4◦Cf o r
15 minutes, washed twice with CSB, and stained with the
secondary antibody for 15 minutes. Following incubation,
100μL of IntraPrep reagent 1 was added for ﬁxation. After
vigorous vortexing, the cells were incubated for 15 minutes
at room temperature. After one wash with PBS, 100μLo fI n -
traPrep reagent 2 was added, and then the mixture was in-
cubated for 5 minutes at room temperature for permeabi-
lization. Next, the neutrophils were incubated with the pri-
mary antibody at 4◦C for 15 minutes, and the intracellular
IL-8 receptors were incubated with the secondary antibody
for 15 minutes. Following these incubations, the cells were
washed once with CSB and resuspended in PBS containing
1%formaldehyde.Subsequently,ﬂowcytometryanalysiswas
performed.
2.9. Westernblotting
Thepretreatedneutrophilswerelysedina“lysisbuﬀer”com-
prising50mMHEPES(pH7.4),150mMNaCl,1mMEDTA,
1% Triton X-100, 10% Glycerol, 1mM NaF, 2mM Na or-
thovandate, 0.1nM phenylmethylsulfonyl ﬂuoride, 5μg/mL
leupeptin, 4.6μg/mL aprotinin, and 3.5ng/mL Pepstatin A.
Proteins in the cell lysates were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) un-
der reducing conditions and then blotted onto nitrocellulose
membranes (Hybond C+, Amersham Pharmacia Biotech,
UK). The membranes were blocked in NET buﬀer (50mM
Tris-HCl, pH 7.5, 150mM NaCl, 5mM EDTA, 0.05% Triton
X-100) containing 1% gelatin and then incubated sequen-
tially with the respective antibodies and rabbit or mouse IgG
TrueBlot (eBioscience, San Diego, Calif, USA). The protein
bands were visualized with an enhanced chemiluminescence
(ECL) detection kit (Amersham Pharmacia Biotech).
2.10. Immunoprecipitationanalysis
The neutrophil lysate was obtained as described above. The
lysates were precleared by incubation for 1 hour with True-
Blot antimouse Ig IP beads (eBioscience). The primary anti-
body and TrueBlot antimouse Ig IP beads were added to the
preclearedlysates.Thebeadswerewashedinawashingbuﬀer
[50mM HEPES (pH 7.4), 150mM NaCl, 0.1% Triton X-100,
10% Glycerol] and resuspended in the SDS sample buﬀer.
Immunoprecipitation and western blotting were performed
as described above.
2.11. DeterminationofIL-8receptorsrecycling
onthecellsurface
Theprocedureusedtodeterminereceptorrecyclingwassim-
ilar to that used to determine receptor internalization. The4 Mediators of Inﬂammation
samples were allowed to undergo a receptor recovery process
that was performed as previously described [17]. In brief, in-
ternalization was induced by exposure to 1000ng/mL hrIL-
8f o r3 0m i n u t e sa t3 7 ◦C .I no r d e rt oa l l o wr e c e p t o rr e c o v -
ery, the cells were washed once and resuspended in BSA
medium at 37◦C for the speciﬁed time periods. The neu-
trophils were incubated with the speciﬁed concentrations of
curcumin during the IL-8 receptor recovery process. To re-
duce the contribution of de novo protein synthesis to recep-
tor reappearance on the cell membrane, cell samples under-
going receptor recovery were incubated with medium con-
taining 10μg/mL cycloheximide. Following incubation, the
cells were washed and labeled at 4◦C with anti-CXCR1 or
anti-CXCR2 antibody and mouse IgG, as described above.
The FACS calibur system was used to analyze 10000 live cell
events.
2.12. Statisticalanalysis
Data are expressed as mean values ± standard error. Statis-
tical signiﬁcance was determined by Student t tests and cor-
relation coeﬃcients. A P value less than .05 was considered
signiﬁcant.
3. RESULTS
3.1. Effectofcurcuminonneutrophil
chemotacticactivity
Chemotaxis was assessed using microchemotaxis chambers
covered with polyethylene terephthalate membranes. We ob-
served that neutrophils rapidly passed through the mem-
branes toward the wells of the lower chamber containing
hrIL-8. After 1 hour of incubation, the neutrophils that
passed through the ﬁlter to the lower wells were counted. In
Figures 1(a) and 1(b) triplicate results of the average num-
ber of migrating neutrophils/5 hpf are shown. These data re-
vealed that the chemotactic activity of neutrophils was stim-
ulated by hrIL-8 in a dose-dependent manner.
To determine the eﬀect of curcumin on neutrophil
chemotaxis, the neutrophils were incubated with various
concentrations of curcumin added to the wells of the up-
per chamber. As shown in Figures 1(c) and 1(d),c u r -
cuminsigniﬁcantlyinhibitedcellmigrationinducedbyhrIL-
8 (10000pg/mL) at concentrations of 10–100μM in a dose-
dependent manner.
The obtained neutrophils were cultured in the presence
of various doses of curcumin for 2 hours. The viability of
neutrophils was examined using trypan blue staining. Cur-
cumin did not aﬀect neutrophil viability at a concentration
up to 100μM when compared with the control treatment
(data not shown). In these experiments, agonist stimulation
at 37◦C did not cause a signiﬁcant decrease in the cell num-
ber or reduction in cell viability (>99% by trypan blue exclu-
sion).
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Figure 1: The eﬀect of curcumin on the chemotactic activity in hu-
man neutrophils. Chemotaxis was assessed by using 24-well mi-
crochemotaxischamberscoveredwithmembranes(3μmporesize).
The lower wells were ﬁlled with a medium containing various con-
centrations of hrIL-8, and 1 × 106 PMNs were then added to each
well of the upper chamber. (a) The neutrophils that passed through
theﬁlterwerecounted.(b)hrIL-8inducedneutrophilchemotaxisin
a dose-dependent manner. Next, the neutrophils were preincubated
withvariousconcentrationsofcurcuminfor2hoursat37◦C.Prein-
cubated neutrophils were added to each well of the upper cham-
ber, and the chemotaxis activity was assessed as described above. (c)
Cells were counted after curcumin treatment. (d) Curcumin signif-
icantly inhibited the chemotactic activity induced by hrIL-8 at con-
centrations of 10–100μM in a dose-dependent manner. The neu-
trophil chemotactic activity determined in triplicate was expressed
astheaveragenumberofmigratingneutrophils/5hpf.Eachbarrep-
resents the mean ± SE of three individual experiments. Statistical
signiﬁcance versus the control: ∗P<. 05.Masafumi Takahashi et al. 5
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Figure 2: Curcumin blocks the hrIL-8-induced intracellular Ca2+ en-
hancement.Neutrophils(1×106 c ells/mL)tr eat edwithvariousc o n-
centrations of curcumin for 2 hours were loaded with 13μM Fura
Red-AM in HEPES-buﬀered saline for 90 minutes at 37◦Ci naC O 2
incubator.AdditionofhrIL-8(50ng/mL)increasedtheintracellular
calcium concentration and caused a decrease in the Fura Red ﬂuo-
rescence. The change in the ﬂuorescence intensity at 640nm was
analyzed on an FACS calibur system. The mean channel of the ﬂu-
orescence was analyzed by CellQuest software. The data obtained
showeddiﬀerencesbetweenthemeanchannelvaluebeforeandafter
hrIL-8 stimulation. Curcumin signiﬁcantly inhibited the increase in
the intracellular calcium concentrations in a dose-dependent man-
ner. Data was obtained from three independent experiments and
was represented.
3.2. Curcumininhibitstheincreaseintheintracellular
calciumconcentration
To determine the eﬀect of curcumin on intracellular signal-
ing due to IL-8-mediated IL-8 receptor stimulation, we in-
vestigated the eﬀects of changes in the intracellular calcium
concentration.
Approximately 1 × 106 neutrophils treated with various
concentrations of curcumin for 2 hours were loaded in a
volume of 100μL in culture tubes containing 13μMF u r a
Red-AM in HEPES-buﬀered saline (135mM NaCl, 4.6mM
KCl, 1.2 mM MgCl2,11mMHEPES,11mMglucose,1.5mM
CaCl2 at pH 7.4) for 90 minutes at 37◦Ci naC O 2 incuba-
tor. As shown in Figure 2, hrIL-8 (50ng/mL) increased the
intracellular calcium concentration, and this phenomenon
was demonstrated as a decrease in the Fura Red ﬂuorescence.
Curcumin signiﬁcantly inhibited the increase in the intra-
cellular calcium concentrations in a dose-dependent man-
ner. These data suggested that curcumin reduced neutrophil
chemotaxisbyaﬀectingsignaltransductionmediatedbyIL-8
via the IL-8 receptors.
3.3. Curcuminpromotesthedownregulationof
theexpressionofIL-8receptorson
theneutrophilsurface
To investigate the status of IL-8 receptors after curcumin
treatment, we examined the IL-8 receptor on the cell surface
by FACScan using the CXCR1 and CXCR2 monoclonal anti-
bodies.
As shown in Figure 3, both CXCR1 and CXCR2 present
on the cell surface were downregulated by hrIL-8 (50ng/mL)
treatment due to receptor internalization. In addition, both
IL-8 receptors present on the surface of neutrophils treated
with curcumin were downregulated by rIL-8 (50ng/mL) to a
greater extent. These data revealed that the amounts of intra-
cellular CXCR1 and CXCR2 are relatively increased by cur-
cumin treatment. These ﬁndings indicated that the regula-
tion of neutrophil chemotaxis may depend on the decreased
amounts of CXCR1 and CXCR2 present on the cell surface.
3.4. RegulationofCXCR1andCXCR2bycurcumin
withoutdenovoproteinsynthesis
To determine whether the production of IL-8 receptors in
neutrophils has inﬂuenced the curcumin treatment, we also
evaluated the change of IL-8 receptors without de novo syn-
thesis which are transported to the cell surface.
Neutrophils were incubated with cycloheximide, a strong
protein synthesis inhibitor, at a concentration of 10ng/mL.
FACScan analysis showed the same decrease pattern of the
amount of IL-8 receptor present on the cell surface. Cyclo-
heximide treatment did not alter the reduction of IL-8 recep-
tors after hrIL-8 treatment in curcumin-treated neutrophils
(see Figure 4). These ﬁndings suggested that de novo synthe-
sis of IL-8 receptors may not be associated with the changes
due to curcumin treatment of IL-8 receptors present on the
cell surface.
3.5. Effectofcurcuminonthedistributionof
IL-8receptors
To investigate the inﬂuence of curcumin on the degradation
of IL-8 receptors, we determined the total cellular amount of
IL-8 receptors by ﬂow cytometry.
The expression of total cellular amount of IL-8 recep-
torsrevealednosigniﬁcantdiﬀerencebetweenthecurcumin-
treated and the control neutrophils (see Figure 5). However,
in the curcumin-treated neutrophils, the IL-8 receptors on
the cell surface showed obviously decrease than the control
(see Figures 3(e) and 3(f)).
Taken together, these data suggested that curcumin
changes the cellular distribution of IL-8 receptors. The in-
crement of the intercellular IL-8 receptors may account for
the decrement of IL-8 receptors on the cell surface after cur-
cumin treatment.
3.6. CurcuminblocksCXCRrecycling
In order to investigate the impact on the recycling path-
way, the obtained neutrophils were pretreated with hrIL-8
(1000ng/mL) at 37◦C for 30 minutes. They were resus-
pended for the speciﬁed time periods in hrIL-8-free medium
containing various concentrations of curcumin. Representa-
tive data of CXCR1 recycling for 30 minutes and CXCR2 re-
cycling for 120 minutes are shown in Figure 6. The recycling6 Mediators of Inﬂammation
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Figure3:EﬀectofcurcuminontheinternalizationoftheIL-8receptor.Theobtainedneutrophilswerepreincubatedinmediumwithorwithout
50μM curcumin at 37◦C for 2 hours. They were washed and incubated at 37◦C for 2 hours with 50ng/mL hrIL-8 diluted in BSA medium,
while no hrIL-8 was added to the control tubes. The expressions of CXCR1 and CXCR2 present on the cell surface were determined with
anti-CXCR1 ((a), (c), (e)) or anti-CXCR2 ((b), (d), (f)) mouse monoclonal antibodies by measuring the content of APC-conjugated anti-
mouse IgG antibody using ﬂow cytometry. CXCR1 (a) and CXCR2 (b) present on the surface of the untreated neutrophils were decreased
by internalization after hrIL-8 (50ng/mL) exposure. The amount of CXCR1 present on the cell surface slightly decreased after curcumin
treatment (c), while that of CXCR2 shows a very slight change (d). A more dynamic decrease in the amount of CXCR1 (e) and CXCR2 (f)
was observed in curcumin-treated neutrophils than in the untreated neutrophils after hrIL-8 treatment. Shown are representatives of three
independent experiments with similar results.
of CXCR1 and CXCR2 to the cell membrane was blocked by
curcumin in a dose-dependent manner (see Figure 6).
3.7. Rab11interactionwithCXCR
In order to assess the interaction of the small GTPase Rab11
that functionally regulates cytosolic traﬃcking of IL-8 re-
ceptors in human primary neutrophils, we analyzed anti-
CXCR1 and anti-CXCR2 immunoprecipitates for the pres-
ence of Rab11.
Western blotting showed that the total amount of the
Rab11 protein was not altered by curcumin treatment (see
Figure 7(a)). Immunoprecipitation studies were performed
to determine the association of CXCR1 and CXCR2 withMasafumi Takahashi et al. 7
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Figure 4: Eﬀect of curcumin on the reduction of the IL-8 receptors without protein synthesis. After preincubation of neutrophils with curcumin
(50μM) for 2 hours, they were incubated with hrIL-8 (50ng/mL) for 30 minutes. While the neutrophils were incubating, cycloheximide
(10μg/mL) was added to determine whether the de novo synthesis has any eﬀect on the reduction of IL-8R by curcumin. The same decrease
pattern of the amount of IL-8 receptor present on the cell surface was observed with cycloheximide. The inhibition of protein synthesis did
not alter the reduction of both CXCR1 and CXCR2 by curcumin treatment. Shown are representatives of three independent experiments
with similar results.
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Figure 5: The impact of curcumin on the total amount of IL-8 receptors. Both IL-8 receptors on the cell surface and in the cytosol were stained
using the permeabilization technique. The total cellular amount of the receptors was determined by ﬂow cytometry. (a) The expression of
total IL-8 receptors revealed no signiﬁcant diﬀerence between curcumin-treated and untreated neutrophils. (b) Furthermore, in case of the
curcumin-treated neutrophils, the total amount of IL-8 receptors showed a smaller decrease after IL-8 treatment than that shown by the
receptors on the cell surface of curcumin-treated neutrophils (see Figures 3(e) and 3(f)).8 Mediators of Inﬂammation
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Figure 6: Curcumin blocks the recovery process of IL-8 receptors. The
eﬀect of curcumin on the recycling of IL-8 receptors to the surface
of neutrophils was examined by FACScan. Internalization was in-
duced by 30-minute exposure to 1000ng/mL hrIL-8 at 37◦C. In or-
der to facilitate receptor recovery, the cells were washed once and
resuspended in BSA medium containing 10μg/mL cycloheximide
with various concentrations of curcumin at 37◦C for the speciﬁed
time periods. Following incubation, the cells were labeled as de-
scribed above. (a) The cells were treated under the following con-
ditions: (1) untreated cells; (2) cells treated with hrIL-8 and no re-
covery; (3) cells treated with hrIL-8 and recovery for 30 minutes;
(4) cells treated with hrIL-8 and recovery for 30 minutes with cur-
cumin (0.5μM); (5) cells treated with hrIL-8 and recovery for 30
minutes with curcumin (5μM); and (6) cells treated with hrIL-8
and recovery for 30 minutes with curcumin (50μM). (b) The cells
were treated under the following conditions: (1) untreated cells; (2)
cellstreatedwithhrIL-8andnorecovery;(3)cellstreatedwithhrIL-
8 and recovery for 120 minutes; (4) cells treated with hrIL-8 and
recovery for 120 minutes with curcumin (0.5μM); (5) cells treated
with hrIL-8 and recovery for 120 minutes with curcumin (5μM);
and (6) cells treated with hrIL-8 and recovery for 120 minutes with
curcumin (50μM). Curcumin treatment blocked the recycling of
CXCR1 (a) and CXCR2 (b) to the cell surface of the human pri-
mary neutrophils in a dose-dependent manner. Representative data
is shown. Shown are representatives of three independent experi-
ments with similar results.
Rab11 after curcumin treatment. Both receptors showed in-
teractionwithRab11(seeFigures7(b),7(c),and7(d)).These
associations in both receptors were enhanced after curcumin
treatment.
4. DISCUSSION
Various inﬂammations cause biological responses such as
neutrophil activation through proinﬂammatory cytokine re-
ceptors; however, the mechanisms that control these cy-
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Figure 7: Rab-11 interaction with CXCR. (a) Proteins in the neu-
trophil lysates were separated by SDS-PAGE followed by blotting
ontonitrocellulosemembranes.Theproteinbandsweredetectedby
western blotting as described above. The amount of Rab11 protein
was not remarkably diﬀerent in curcumin-treated and untreated
neutrophils. We analyzed anti-CXCR1 and CXCR2 immunoprecip-
itates for the presence of Rab-11. In primary neutrophils, analy-
sis of the immunoprecipitates with anti-CXCR1 and anti-CXCR2
monoclonal antibodies supported the existence of an association
withRab-11.(b)CoimmunoprecipitationofRab11withCXCR1re-
vealed an increase after curcumin treatment. (c) After hrIL-8 expo-
sure, coimmunoprecipitation of Rab11 with CXCR2 was enhanced
though the association of Rab11 with CXCR2 not really appearing
to be enhanced after curcumin treatment without IL-8 treatment.
(d) In particular, curcumin-treated neutrophil showed remarkable
increase ratio compared to the untreated neutrophil after IL-8 stim-
ulation. Representative of three separate experiments are shown.
The results of immunoprecipitates are expressed as an intensity ra-
tioofthedensitometryunitsrelativetotheamountofthebasalRab-
11. Results are presented as the mean ± SD from three experiments.
tokine receptors remain unclear. In this study, we reported
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was signiﬁcantly inhibited in a dose-dependent manner by
curcumin treatment. This inhibition did not result from
curcumin-induced cell cytotoxicity, since the total number
of cells and the cell viability at the end of the culture period
did not diﬀer with the culture conditions. Antichemotaxis
provided important evidence for the anti-inﬂammatory re-
sponses due to curcumin treatment because neutrophil ac-
cumulation is a primary response in local inﬂammation,
and this is followed by activation and inﬁltration of neu-
trophils.
Numerous chemokines play a crucial role in these bio-
logical responses. In particular, IL-8 is a strong neutrophil
chemoattractant in the local inﬂammatory site. Other re-
searchers, including our group, have already reported that
curcumin inhibits the production of IL-8 by monocytes,
macrophages, and other lymphatic cells [8]. The blockage of
IL-8 production should be one of the key factors in the reg-
ulation of inﬂammation caused by neutrophils. Another way
in which the inﬂammation elicited by neutrophils can be in-
hibited is by the interception of IL-8 promoted signal trans-
duction in neutrophils.
In this study, neutrophils chemotaxis via hrIL-8 was sig-
niﬁcantly inhibited by curcumin. Experimental studies have
demonstrated that human anti-CXCR monoclonal antibod-
ies blocked IL-8-dependent cellular functions including neu-
trophil chemotaxis directly [34]. Our previous study re-
ported that exogenous IL-8 could not recover response to IL-
8 receptor by curcumin treatment [8]. Therefore, we exam-
ined about IL-8 signal transduction through IL-8 receptors
after curcumin treatment.
In our study, a Ca2+ mobilization assay conﬁrmed that
IL-8 signal transduction through IL-8 receptors was blocked
by curcumin treatment. Regarding the mechanisms of IL-8
receptorsignaling,itiswidelyacceptedthatligand-promoted
internalization is one of the most important initiating path-
ways [19, 21, 22, 35]. In neutrophils, IL-8 stimulated the
β-arrestin-dependent internalization of the CXCR receptor
[19,36].Uponagonistbinding,CXCR1andCXCR2receptor
activation is followed by receptor phosphorylation at multi-
ple serine residues and subsequent desensitization of the re-
ceptor to further stimulation [17, 21, 37]. These events are
usually accompanied by receptor endocytosis and/or recy-
cling of the receptor.
In our study, FACScan analysis showed a decrease in the
amount of both CXCR1 and CXCR2 present on the cell
surface after curcumin treatment. In particular, after IL-8
promotedreceptorinternalization,theamountofIL-8recep-
tors on the neutrophil cell surface is signiﬁcantly decreased.
Curcumin has been shown to inhibit NF-kB activity and to
block a signal upstream of the NF-kB-inducing kinase and
IKK and curcumin is suggested to regulate some transcrip-
tional factors [9]. After blocking new protein synthesis by
cycloheximide, our experiments showed the same decrease
pattern in the IL-8 receptors present on the cell surface. This
result suggests that the decrease in the amount of IL-8 re-
ceptors present on the cell membrane was not only due to
degradation. The possibility of the receptor shedding should
be considered, but there is no convincible report concern-
ing the shedding of IL-8R. Moreover, Figure 5 demonstrated
thatthetotalamountofCXCRisnotdiﬀerentaftercurcumin
treatment, we consider that the possibility of the receptor
shedding is deniable. This ﬁnding was consistent with those
of our previous studies, suggesting that curcumin may aﬀect
the ligand-promoted traﬃcking pathway of the IL-8 receptor
[8].
The traﬃcking pathway of IL-8 receptors is known to
comprise two diﬀerent transport directions including inter-
nalization and externalization. Either promotion of internal-
ization or inhibition of externalization should induce a de-
crease in the amount of receptors present on the cell sur-
face. Our experiments based on FACScan conﬁrmed that
curcumin delayed the traﬃcking pathway in the cytosol, and
this resulted in the blockage of the recycling pathway to the
cell surface. The Rab GTPase family is known to play an
essential role in the cellular traﬃcking pathway. In particu-
lar, Rab11 is associated with the recycling compartment and
trans-Golgi network (TGN) membranes, and it controls the
slow endosomal recycling pathway as well as the traﬃcf r o m
the TGN [24, 26, 38]. The small GTPase Rab11 has been re-
ported to regulate the traﬃcking of CXCR2 through the re-
cycling endosome [27, 28]. Our immunoprecipitation study
also showed the association of CXCR2 and Rab11 in primary
neutrophils. Moreover, an association between CXCR1 and
Rab11 was indicated. Further analyses are required to de-
termine the mechanism of blockage of IL-8 receptor recy-
cling;however,thisistheﬁrstreportontheassociationofthe
IL-8 receptor with Rab11 in primary cultured neutrophils.
Following curcumin treatment, the binding of Rab11 and
CXCR1 and CXCR2 appearedto be moreprominent. There-
cyclingprocessfromtheendosometothecellsurfaceremains
unclear; however, stacking of the receptor proteins with the
transporter proteins may be responsible for the deposition of
IL-8 receptors in the endosomes. Therefore, it can be con-
sidered that these ﬁndings are consistent with those of previ-
ous studies that showed a reduction in the recycling of IL-8
receptors. Although our study had several limitations, these
data suggest that curcumin might induce the stacking of the
Rab11 vesicle complex with CXCR1 and CXCR2 in the endo-
cytic pathway.
Moreover, curcumin is suggested to aﬀect signal trans-
duction from the other transmembrane receptors, such as
transferrin receptor and the m4 muscarinic acetylcholine
receptor, whose recycling is regulated by Rab11 through
cytosolic traﬃcking pathways [39]. Since curcumin is also
known to be an inhibitory factor for several serine/threonine
kinases, such as PKC [40]a n dI K K[ 9], GTPases activ-
ity might be inhibited by kinase dephosphorylation, and
this could result in an increased stability of the trans-
porter protein association. Although phosphorylation is a
crucial determinant of IL-8 receptor internalization, our
western blotting data showed no signiﬁcant diﬀerence in
the mobility of the IL-8 receptor due to phosphorylation
(data not shown). Previous studies were unable to com-
pletely explain the delays in CXCR1 and CXCR2 recycling
to the cell surface by curcumin; however, it is possible
that curcumin has an eﬀect on the transport system due to10 Mediators of Inﬂammation
recycling of the endosomes because the association of the
IL-8 receptor with Rab11 after curcumin treatment was in-
creased.
Recent studies suggested that curcumin has various
mechanisms for bioactivity. These ﬁndings have identiﬁed
curcumin as a regulator of kinase activities, a regulator of
transcriptions, and a modulator of oxidative agent. Although
there is no evidence about direct interact with membranous
receptor, some investigators suggested that curcumin have a
unique role in a modiﬁcation of membranous or cytoskele-
ton system [41]. Previous study cannot fully explain about
mechanisms of regulation of IL-8 receptor by curcumin, but
our result is partially consistent with those of prior studies
showing modiﬁcation of cytosol components by curcumin
[42].
As for our studies’ limitation, we would have included an
inactive analog in our study, if one had been available. There
areseveralanalogsandmetaboliteswhichhavebeenreported
[43],butalmostanalogshaveasimilar andmodiﬁed eﬀectof
curcumin, which are not useful as an inactive control in this
study.
In conclusion, our data provide some noteworthy evi-
dence that curcumin inhibits neutrophil chemotactic activ-
ity caused by IL-8 chemokine. Curcumin is suggested to in-
hibit CXCR1 and CXCR2 recycling; this results in a decrease
in neutrophil chemotaxis. In addition, we demonstrated that
curcumin treatment changed the intercellular traﬃcking of
the IL-8 receptor in neutrophils. These mechanisms may
involve inhibition of the endosomal transport pathway by
members of the Rab11 family.
Our study suggests that curcumin aﬀects numerous
bioactivities that involve signal transduction through the IL-
8 receptor. Therefore, curcumin is able to function as a po-
tent anti-inﬂammatory agent that regulates the receptor traf-
ﬁcking pathway in cytosol. In vivo use of curcumin might
be beneﬁcial for patients with inﬂammation due to the en-
hanced production of various proinﬂammatory cytokines,
such as ARDS and pancreatitis as well as patients with the
paraneoplastic syndrome. Recently a great deal of evidence
has revealed that cytokine overreaction contributes to the
severity of the systemic inﬂammation response syndrome
(SIRS) [44]. Therefore, the control of cytokine signal trans-
duction may play an important role in the inﬂammation
therapy.
The unique mechanisms by which curcumin regulates
the receptor transport system should be further elucidated.
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